PointState Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

PointState Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-325,000	Closed	-$17.4M	–	152
2016 Q1	$17.4M	Buy	+325,000	New	+$24M	0.47%	33
2014 Q2	–	Sell	-288,959	Closed	-$5.78M	–	172
2014 Q1	$5.78M	Buy	+288,959	New	+$5.6M	0.09%	86

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

PointState Capital's ANAC Position: Q2 2016 in Review

PointState Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 325,000 shares — an estimated $17.4M sold.

PointState Capital first reported a position in ANAC in Q1 2014 and held it in 2 quarters. The position peaked at $17.4M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

PointState Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
PointState Capital sold 325,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $17.4M.
PointState Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 2 quarters.
PointState Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $17.4M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.